Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study ...Middle East

HANGZHOU, China, Sept. 5, 2024 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus Medtech, 02500.HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced that its in-house developed next-generation balloon-expandable...

Hence then, the article about venus medtech venus vitae completes first two implantations in smart align pivotal clinical study was published today ( Thursday 05/09/2024 - 11:44 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study )

Also on site :

• Werk Room Weekly: Briar Blush faints on-stage, beefs with Mia Starr, more .. ‘Drag Race’ S18 E4 Recap
• ‘Change is inevitable’: What is next for Iran?
• Amazon Has the 'Most Comfortable' Carhartt Jogger Pants on Sale for Under $50